GMTX - Gemini Therapeutics, Inc. Stock Price, Fair Value and News

$59.55+2.20 (+3.84%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

GMTX Price Action

Last 7 days

-8.5%

Last 30 days

17.8%

Last 90 days

24.0%

Trailing 12 Months

22.9%

GMTX RSI Chart

GMTX Valuation

Market Cap

1.8B

Price/Earnings (Trailing)

-17.12

Price/Sales (Trailing)

9.5

EV/EBITDA

-15.32

Price/Free Cashflow

-21.04

GMTX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

GMTX Fundamentals

GMTX Revenue

Revenue (TTM)

186.6M

Rev. Growth (Yr)

24.55%

Rev. Growth (Qtr)

3.7K%

GMTX Earnings

Earnings (TTM)

-103.5M

Earnings Growth (Yr)

-88.35%

Earnings Growth (Qtr)

-0.94%

GMTX Profitability

EBT Margin

-55.36%

Return on Equity

-22.11%

Return on Assets

-20.9%

Free Cashflow Yield

-4.75%

GMTX Investor Care

Shares Dilution (1Y)

23.27%

Diluted EPS (TTM)

-3.94

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	152.5M	186.6M	0	0
2023	73.3M	109.6M	145.9M	182.2M
2022	0	162.0K	656.0K	37.0M
2021	0	25.8K	14.5K	16.0K
2020	0	0	0	37.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About Gemini Therapeutics, Inc.

WEBSITE	geminitherapeutics.com

Gemini Therapeutics, Inc. Frequently Asked Questions

What is the ticker symbol for Gemini Therapeutics, Inc.? What does GMTX stand for in stocks?

GMTX is the stock ticker symbol of Gemini Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Gemini Therapeutics, Inc. (GMTX)?

As of Mon Nov 18 2024, market cap of Gemini Therapeutics, Inc. is 1.77 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GMTX stock?

You can check GMTX's fair value in chart for subscribers.

Is Gemini Therapeutics, Inc. a good stock to buy?

The fair value guage provides a quick view whether GMTX is over valued or under valued. Whether Gemini Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Gemini Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GMTX.

What is Gemini Therapeutics, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Nov 18 2024, GMTX's PE ratio (Price to Earnings) is -17.12 and Price to Sales (PS) ratio is 9.5. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GMTX PE ratio will change depending on the future growth rate expectations of investors.